196 related articles for article (PubMed ID: 27802225)
1. Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.
Tong Z; Wang W; Luo W; Lv J; Li H; Luo H; Jia J; He R
J Alzheimers Dis; 2017; 55(3):1031-1038. PubMed ID: 27802225
[TBL] [Abstract][Full Text] [Related]
2. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
[TBL] [Abstract][Full Text] [Related]
3. A rapid and sensitive fluorescence method for detecting urine formaldehyde in patients with Alzheimer's disease.
Ai L; Wang J; Li T; Zhao C; Tang Y; Wang W; Zhao S; Jiang W; Di Y; Fei X; Luo H; Li H; Luo W; Yu Y; Lin W; He R; Tong Z
Ann Clin Biochem; 2019 Mar; 56(2):210-218. PubMed ID: 30373389
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for endogenous formaldehyde elevation in SAMP8 mouse.
Qiang M; Xiao R; Su T; Wu BB; Tong ZQ; Liu Y; He RQ
J Alzheimers Dis; 2014; 40(4):1039-53. PubMed ID: 24583407
[TBL] [Abstract][Full Text] [Related]
5. Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
Zhang N; Zhang L; Li Y; Gordon ML; Cai L; Wang Y; Xing M; Cheng Y
J Alzheimers Dis; 2017; 60(1):87-95. PubMed ID: 28777752
[TBL] [Abstract][Full Text] [Related]
6. Qualitative Analysis of Mini Mental State Examination Pentagon in Vascular Dementia and Alzheimer's Disease: A Longitudinal Explorative Study.
Lo Buono V; Bonanno L; Corallo F; Foti M; Palmeri R; Marra A; Di Lorenzo G; Todaro A; Bramanti P; Bramanti A; Marino S
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1666-1672. PubMed ID: 29503167
[TBL] [Abstract][Full Text] [Related]
7. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.
Liu-Seifert H; Siemers E; Price K; Han B; Selzler KJ; Henley D; Sundell K; Aisen P; Cummings J; Raskin J; Mohs R;
J Alzheimers Dis; 2015; 47(1):205-14. PubMed ID: 26402769
[TBL] [Abstract][Full Text] [Related]
9. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
Rasovska H; Rektorova I
J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
[TBL] [Abstract][Full Text] [Related]
10. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
[TBL] [Abstract][Full Text] [Related]
11. Validation of Addenbrooke's cognitive examination for detecting early dementia in a Japanese population.
Yoshida H; Terada S; Honda H; Ata T; Takeda N; Kishimoto Y; Oshima E; Ishihara T; Kuroda S
Psychiatry Res; 2011 Jan; 185(1-2):211-4. PubMed ID: 20537725
[TBL] [Abstract][Full Text] [Related]
12. Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease.
Smith ER; Nilforooshan R; Weaving G; Tabet N
J Alzheimers Dis; 2011; 24(2):327-33. PubMed ID: 21239851
[TBL] [Abstract][Full Text] [Related]
13. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
[TBL] [Abstract][Full Text] [Related]
14. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment.
Ma L; Chen J; Wang R; Han Y; Zhang J; Dong W; Zhang X; Wu Y; Zhao Z
J Clin Neurosci; 2015 Apr; 22(4):649-52. PubMed ID: 25564275
[TBL] [Abstract][Full Text] [Related]
15. The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.
Liu CH; Bu XL; Wang J; Zhang T; Xiang Y; Shen LL; Wang QH; Deng B; Wang X; Zhu C; Yao XQ; Zhang M; Zhou HD; Wang YJ
J Alzheimers Dis; 2016 Apr; 52(3):1081-8. PubMed ID: 27079706
[TBL] [Abstract][Full Text] [Related]
16. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.
Wang CS; Pai MC; Chen PL; Hou NT; Chien PF; Huang YC
Int Psychogeriatr; 2013 Nov; 25(11):1839-48. PubMed ID: 23919950
[TBL] [Abstract][Full Text] [Related]
17. The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke.
Srikanth V; Thrift AG; Fryer JL; Saling MM; Dewey HM; Sturm JW; Donnan GA
Int Psychogeriatr; 2006 Jun; 18(2):295-305. PubMed ID: 16734921
[TBL] [Abstract][Full Text] [Related]
18. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
